These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37295240)

  • 1. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer.
    Chen JS; Guo X; Sun JY; Wang MX; Gao XZ; Wang Z; Han JL; Sun H; Zhang K; Liu C
    Bioorg Chem; 2023 Sep; 138():106623. PubMed ID: 37295240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives.
    Gao XZ; Lv XT; Zhang RR; Luo Y; Wang MX; Chen JS; Zhang YK; Sun B; Sun JY; Liu YF; Liu C
    Bioorg Chem; 2021 Apr; 109():104694. PubMed ID: 33601141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.
    Yang J; Hu S; Wang C; Song J; Chen C; Fan Y; Ben-David Y; Pan W
    Eur J Med Chem; 2020 Jan; 186():111898. PubMed ID: 31784186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
    Tian F; Ding D; Li D
    Int J Oncol; 2015; 46(6):2355-63. PubMed ID: 25872479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.
    Wang J; Wang HY; Shen Y; Liang D; Wang HY; Zhang SQ; Cao YX; Cao L
    Anticancer Drugs; 2019 Oct; 30(9):900-908. PubMed ID: 30913062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
    Songyang Y; Song T; Shi Z; Li W; Yang S; Li D
    Gene; 2021 Feb; 768():145309. PubMed ID: 33197518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway.
    Zou L; Li X; Lin J; Fang X; Lin J; Zhang L; Zhang Y; Liang Y; Ren J; Liu Y; Huang Z
    J Pharm Pharmacol; 2024 Mar; 76(3):269-282. PubMed ID: 38241189
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Thongsom S; Racha S; Ei ZZ; Petsri K; Aksorn N; Chamni S; Panpuang V; Zou H; Chanvorachote P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway.
    Chen B; Song Y; Zhan Y; Zhou S; Ke J; Ao W; Zhang Y; Liang Q; He M; Li S; Xie F; Huang H; Chan WN; Cheung AHK; Ma BBY; Kang W; To KF; Xiao J
    Cancer Lett; 2022 Sep; 543():215783. PubMed ID: 35700820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and in vitro evaluation of fangchinoline derivatives as potential anticancer agents.
    Zhang YC; Gao XZ; Liu C; Wang MX; Zhang RR; Sun JY; Liu YF
    Bioorg Chem; 2020 Jan; 94():103431. PubMed ID: 31759658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fangchinoline exerts antitumour activity by suppressing the EGFR‑PI3K/AKT signalling pathway in colon adenocarcinoma.
    Jiang F; Ren S; Chen Y; Zhang A; Zhu Y; Zhang Z; Li Z; Piao D
    Oncol Rep; 2021 Jan; 45(1):139-150. PubMed ID: 33416119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells.
    Liu X; Jiang Q; Liu H; Luo S
    Biol Res; 2019 Feb; 52(1):7. PubMed ID: 30797236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fangchinoline Inhibited Proliferation of Neoplastic B-lymphoid Cells and Alleviated Sjögren's Syndrome-like Responses in NOD/Ltj Mice via the Akt/mTOR Pathway.
    Shao Y; Fu J; Zhan T; Ye L; Yu C
    Curr Mol Pharmacol; 2022; 15(7):969-979. PubMed ID: 35176991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
    Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G
    Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft.
    Wang CD; Huang JG; Gao X; Li Y; Zhou SY; Yan X; Zou A; Chang JL; Wang YS; Yang GX; He GY
    Biosci Biotechnol Biochem; 2010; 74(3):488-93. PubMed ID: 20208355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer.
    Dong C; Chen Y; Li H; Yang Y; Zhang H; Ke K; Shi XN; Liu X; Li L; Ma J; Kung HF; Chen C; Lin MC
    Int J Biol Sci; 2019; 15(7):1523-1532. PubMed ID: 31337981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.